Cerity Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Sell
1,009,842
-1,299,197
-56% -$15.5M 0.02% 617
2026
Q1
$13.8M Buy
2,309,039
+1,217,325
+112% +$9.16M 0.02% 560
2025
Q4
$7.83M Sell
1,091,714
-562,133
-34% -$4.44M 0.01% 750
2025
Q3
$17.7M Sell
1,653,847
-10,173
-0.6% -$99.8K 0.03% 406
2025
Q2
$16.1M Buy
1,664,020
+510,976
+44% +$5.27M 0.03% 405
2025
Q1
$17.2M Buy
1,153,044
+501,959
+77% +$7.72M 0.03% 369
2024
Q4
$12.4M Sell
651,085
-16,255
-2% -$265K 0.03% 429
2024
Q3
$12.8M Buy
667,340
+323,308
+94% +$6.7M 0.03% 423
2024
Q2
$7.12M Sell
344,032
-342,462
-50% -$6.81M 0.02% 516
2024
Q1
$12.9M Buy
686,494
+339,782
+98% +$5.83M 0.03% 393
2023
Q4
$5M Buy
+346,712
New +$4.72M 0.02% 538
2023
Q2
Sell
-9,797
Closed -$454K 1864
2023
Q1
$454K Buy
9,797
+630
+7% +$16.9K ﹤0.01% 1342
2022
Q4
$256K Buy
+9,167
New +$234K ﹤0.01% 1215
2022
Q3
Sell
-7,889
Closed -$267K 1234
2022
Q2
$267K Buy
+7,889
New +$276K ﹤0.01% 950

Other funds holding OGN

Cerity Partners's OGN Position: Q2 2026 in Review

Cerity Partners reduced its Organon & Co (OGN) stake by 56% in Q2 2026, selling an estimated $15.5M and leaving 1,009,842 shares worth $13.7M. The position accounts for 0.02% of the portfolio, ranked #617.

Cerity Partners first reported a position in OGN in Q2 2022 and has held it in 14 quarters since. The position peaked at $17.7M in Q3 2025. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Cerity Partners held 1,009,842 shares of Organon & Co worth $13.7M as of Q2 2026.
  • Cerity Partners sold 1,299,197 Organon & Co shares in Q2 2026, an estimated $15.5M.
  • Organon & Co made up 0.02% of Cerity Partners's portfolio in Q2 2026, its #617 holding.
  • Cerity Partners first reported a position in Organon & Co in Q2 2022 and has held it in 14 quarters since.
  • Cerity Partners's Organon & Co position peaked at $17.7M in Q3 2025.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.